Skip to main content
. 2018 Jun 19;9(47):28351–28363. doi: 10.18632/oncotarget.25322

Figure 3. Association of the changing rates of ΔeGFR and ΔSUA with cardiovascular disease, hypertension or diabetes mellitus.

Figure 3

The patients who received medical treatment for cardiovascular disease, hypertension or diabetes mellitus (Yes) showed the larger decrease of ΔeGFR and the larger increase of ΔSUA than those did not (No).